Join @NBTStweets, @blackstone, @Merck, @servier, @RACapitalMgmt, @RBC, @whitelioncapital to bridge the gap between scientific innovation and funding with the expert Investor Panel!
Access the full event guide here: https://t.co/eFidFJUwXv
Register TODAY — the 6th Annual @GbmSummit allows you to collaborate with key decision-makers in the #glioblastomadrug development space.
Unlock curated insights to breakthrough GBM barriers here: https://t.co/8eIdUbw1ae
Register by FRIDAY and save $900: ttps://ter.li/1tfm17
📣Don't miss out! The final chance to save ends this Friday, February 23
Register now to join 100+ of the brightest minds in pharma, biotech, and academia to celebrate our victories, face our challenges, and chart a path forward.
Secure your place here: https://t.co/m2rlF31vgY
Don't miss this opportunity to tackle the common issue of risk-aversity in GBM Funding!
Our expert investor panel is gearing up to provide valuable insights to overcome this frustrating hurdle,
with more experts to be announced!
Full details here: https://t.co/BCdbiHpeSy
Transforming #Glioblastoma: Pharma, biotech, neurosurgeons, academics, and investors unite for this industry-leading event with top companies like @MimiVax_Inc, @Novartis, @bmsnews and more!
Save up to $600 by registering your place now using this link: https://t.co/WIXeYLJYp3
Register TODAY — the 5th Annual @GbmSummit allows you to collaborate with key decision-makers in the #glioblastoma drug development space.
As chair of the event, our CSO @NBTSCSO will speak along with more than 30 leading industry experts: https://t.co/9B00DfHMdS #BTSM
Save up to $1,100 by booking your pass for the 5th Glioblastoma Drug Development Summit by midnight TOMORROW, Nov 17th!
In an exciting time for GBM, there has never been a better moment to unite with your community & break through barriers to saving lives.
https://t.co/tC5uEGd8Dw
After working closely with leading minds in the brain tumor space, we are excited to share the official programme for the 5th Glioblastoma Drug Development Summit! (Boston, March 26-28, 2024)
Check out our packed 3-day agenda here!
https://t.co/7SK4aANiDp
In this retrospective study from @McGillMed, Mohammad et al. identified an association between metformin use and increased overall survival in MGMT promotor methylation positive #glioblastoma
Read more: https://t.co/JuHVqrVgxl
#JNO#MedEd#BTSM#neurooncology#braintumor
We are pleased to share that the FDA accepted our New Drug Application (NDA) and granted priority review for tovorafenib in relapsed or progressive pediatric low-grade glioma (pLGG). Learn more: https://t.co/TrC2Y8fMMH
In the search for better glioblastoma treatment, brain cancer researchers face many challenges. “But if we don’t push it, those patients are not going to get better,” says our Dr. Hussein Tawbi. https://t.co/8gwVADplRZ @Bloomberg @HTawbi_MD #glioblastoma#EndCancer
We're delighted to be attending the 4th @GbmSummit Boston, US. We're looking forward to discussions with key decision-makers in the #glioblastoma drug development space about tackling specific #drugdelivery challenges.
https://t.co/qp0JEYj8Vn
#GBMSummit#ClinicalTrails#BBB#GBM
Don’t miss Candel President and CEO, Dr. @paulpetertak, at the 4th Annual @GbmSummit, where he will discuss how Candel is developing its viral immunotherapies to help improve survival rates & quality of life for people w/ #cancer. Learn more here: https://t.co/e3B8HZtF7V
Looking forward to attending @GBMSummit next week March 14-16. Please reach out to discuss partnership & investment opportunities for #SurVaxM immunotherapy. Phase 2a mOS of 25.9 mos. in nGBM (https://t.co/5WChP9h7sm) https://t.co/QOw6EDOETq
Thanks @UNMCCC! I am grateful to @Novocure for the opportunity to speak at the @GbmSummit. Looking forward to sharing the work of our Brain Tumor Translational Lab🧠 @UNMHSC@UNMCCC, interacting with participants and discussing the new frontiers in treating #glioblastoma#gbm
Congratulations to Dr. Sara Piccirillo, who was invited to speak at the 4th Annual Glioblastoma Drug Development Conference this month in Boston. To learn more about Dr. Piccirillo's work, click here: https://t.co/DOj5D9u61S
The 4th Annual @GBMSummit is 2 weeks away!🧠 Don't miss: #GBMAGILE – An evergreen registrational model for evaluating new treatments for #GBM on March 15 featuring GCAR CEO @meredith_buxton, GCAR CBO Robert Murray, @KaziaTx CEO James Garner, and @NBTStweets CEO @dfarons